(Q46562540)

23 December 2017

title

Pharmacokinetic interaction between efavirenz and carbamazepine after multiple-dose administration in healthy subjects (English)

1 reference

23 December 2017

1 reference

1 reference

1 reference

Ping Ji

1

1 reference

23 December 2017

Bharat Damle

2

1 reference

23 December 2017

Jingdong Xie

3

1 reference

23 December 2017

Steve E Unger

4

1 reference

23 December 2017

Dennis M Grasela

5

1 reference

23 December 2017

Sanjeev Kaul

6

1 reference

23 December 2017

publication date

2 June 2008

1 reference

23 December 2017

The Journal of Clinical Pharmacology

published in

1 reference

23 December 2017

volume

48

1 reference

23 December 2017

issue

8

1 reference

23 December 2017

page(s)

948-956

1 reference

23 December 2017

Prospective study of new-onset seizures in patients with human immunodeficiency virus infection: etiologic and clinical aspects.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319792

Drug therapy of trigeminal neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319792

Ritonavir-induced carbamazepine toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319792

Anticonvulsant and antiretroviral interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319792

Time course of carbamazepine self-induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319792

Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319792

Interactions among drugs for HIV and opportunistic infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319792

Pharmacodynamics of human immunodeficiency virus type 1 protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319792

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319792

Differential modulation of P-glycoprotein expression and activity by non-nucleoside HIV-1 reverse transcriptase inhibitors in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319792

Homozygous CYP2B6 *6 (Q172H and K262R) correlates with high plasma efavirenz concentrations in HIV-1 patients treated with standard efavirenz-containing regimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319792

The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319792

cDNA cloning and sequence and cDNA-directed expression of human P450 IIB1: identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and differential expression of the IIB mRNAs in human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319792

Single-drug therapy with carbamazepine in patients with epilepsy: serum levels and clinical effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319792

A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319792

Clinical side effects of phenobarbital, primidone, phenytoin, carbamazepine, and valproate during monotherapy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319792

Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319792

Urinary metabolites of phenobarbitone, primidone, and their N-methyl and N-ethyl derivatives in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319792

21 January 2018

Identifiers

DOI

10.1177/0091270008319792

1 reference

23 December 2017

1 reference

23 December 2017